Compounds > monocrotaline

monocrotaline and 8-bromocyclic gmp

monocrotaline has been researched along with 8-bromocyclic gmp in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Archer, SL; Cowan, N; DeMaster, EG; Nelson, DP; Rist, K; Weir, EK1
Cho, KW; Han, JH; Kim, SH; Kim, SZ; Lee, SJ; Lim, SH1
Al-Lamki, RS; Berk, J; Li, X; Morrell, NW; Schermuly, RT; Weiss, A; Wu, C; Yang, J1

Other Studies

3 other study(ies) available for monocrotaline and 8-bromocyclic gmp

ArticleYear
Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs.
    Journal of applied physiology (Bethesda, Md. : 1985), 1990, Volume: 68, Issue:2

    Topics: Acetylcholine; Animals; Bradykinin; Cyclic GMP; Endothelium, Vascular; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Lung; Male; Methylene Blue; Monocrotaline; Nitric Oxide; Pulmonary Circulation; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Vasodilation

1990
Attenuation of inhibitory effect of CNP on the secretion of ANP from hypertrophied atria.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:5

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Extracellular Space; Guanylate Cyclase; Heart Atria; In Vitro Techniques; Male; Monocrotaline; Myocardium; Natriuretic Peptide, C-Type; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor

2001
Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Animals; Antihypertensive Agents; Binding Sites; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type II; Bone Morphogenetic Proteins; Cell Proliferation; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Inhibitor of Differentiation Protein 1; Male; Monocrotaline; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Phosphodiesterase 5 Inhibitors; Phosphorylation; Piperazines; Promoter Regions, Genetic; Pulmonary Artery; Purines; Rats; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Sildenafil Citrate; Smad1 Protein; Smad5 Protein; Sulfones; Transfection; Vasodilator Agents

2013